Related Experiment Video
Updated: Aug 21, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Direct cell cycle regulation by the fibroblast growth factor receptor (FGFR) kinase through phosphorylation-dependent
Yongyou Zhang1, Yongshun Lin, Courtney Bowles
1Center for Cancer Biology and Nutrition, Institute of Biosciences and Technology, Texas A & M University System Health Science Center, 2121 W. Holcombe Boulevard, Houston, TX 77030-3303, USA.
Abstract:
Fibroblast growth factors (FGFs) are upstream activators of the mitogen-activated protein kinase pathway and mitogens in a wide variety of cells. However, whether the mitogen-activated protein kinase pathway solely accounts for the induction of cell cycle or antiapoptotic activity of the FGF receptor (FGFR) tyrosine kinase is not clear. Here we report that cell cycle inducer Cks1, which triggers ubiquitination and degradation of p27(Kip1), associates with the unphosphorylated form of FGFR substrate 2 (FRS2), an adaptor protein that is phosphorylated by FGFR kinases and recruits downstream signaling molecules. FGF-dependent activation of FGFR tyrosine kinases induces FRS2 phosphorylation, causes release of Cks1 from FRS2, and promotes degradation of p27(Kip1) in 3T3 cells. Since degradation of p27(Kip1) is a key regulatory step in activation of the cyclin E/A-Cdk complex during the G(1)/S transition of the cell cycle, the results suggest a novel mitogenic pathway whereby FGF and other growth factors that activate FRS2 directly activate cyclin-dependent kinases.
Insights
Fibroblast growth factors (FGFs) activate cell cycle progression by a novel pathway. FGFs release Cks1 from FRS2, promoting p27(Kip1) degradation and cyclin-dependent kinase activation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Fibroblast growth factors (FGFs) are potent mitogens activating signaling pathways.
- The precise mechanisms by which FGF receptor (FGFR) tyrosine kinases induce cell cycle progression and antiapoptotic activity are not fully elucidated.
- The role of the mitogen-activated protein kinase (MAPK) pathway in mediating all FGF effects remains under investigation.
Purpose of the Study:
- To investigate a novel signaling pathway downstream of FGFR tyrosine kinases.
- To determine if the MAPK pathway solely mediates FGF-induced cell cycle progression.
- To elucidate the interaction between FGFR substrate 2 (FRS2), Cks1, and p27(Kip1) in response to FGF stimulation.
Main Methods:
- Co-immunoprecipitation assays to study protein-protein interactions.
- Western blotting to detect protein phosphorylation and degradation.
- Cell cycle analysis in 3T3 cells stimulated with FGF.
Main Results:
- Cell cycle inducer Cks1 associates with the unphosphorylated form of FGFR substrate 2 (FRS2).
- FGF stimulation leads to FGFR activation, FRS2 phosphorylation, and subsequent release of Cks1 from FRS2.
- Degradation of p27(Kip1) is promoted, facilitating the activation of cyclin E/A-Cdk complexes and G(1)/S phase transition.
Conclusions:
- A novel FGF-mediated signaling pathway involves the direct activation of cyclin-dependent kinases.
- This pathway bypasses sole reliance on the MAPK cascade for cell cycle induction.
- FRS2 acts as a crucial adaptor protein linking FGFR activation to cell cycle machinery via Cks1 and p27(Kip1).
Related Concept Videos
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
MAPK Signaling Cascades

